Mainstay Medical

IPO

First and Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain

Public · Dublin, Ireland · Founded 2008 · $259.1M raised

Headquarters
Dublin
Employees
51–200
Founded
2008
Business Model
B2B
Total Funding
$259.1M
Last Round
$125.0M Series DFeb 2024
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 7 investors for this company. The full record is or through the API.

About

Mainstay Medical is a global medical device company focused on developing and commercializing restorative neurostimulation therapies for chronic pain. Founded in 2008 in Minneapolis, Minnesota by Dr. Dan Sachs, the company relocated to Dublin, Ireland in 2012. Its flagship product ReActiv8 is the first FDA-approved implantable device for management of intractable chronic low back pain associated with multifidus muscle dysfunction.

Summary

Mainstay Medical is a Healthcare company based in Dublin, Ireland, founded in 2008. It has raised $259.1M in total across 4 rounds, most recently a $125.0M Series D round in Feb 2024. Investors include Sofinnova Partners, Gilde Healthcare and Viking Global.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Series DSeries DFeb 2024
$125.0M

Sign up to see all 5 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mainstay Medical on Indexed.vc
<a href="https://indexed.vc/companies/mainstay-medical"><img src="https://indexed.vc/api/badge/company/mainstay-medical" alt="Mainstay Medical on Indexed.vc" width="260" height="76" /></a>